MRSN Historical PE Ratio image   This MRSN PE ratio history page last updated 11/15/2024
MRSN Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2024
11/13/2024
2.63-0.09-0.36NA
Q2 2024
8/13/2024
1.35-0.20-0.80NA
Q1 2024
5/9/2024
2.46-0.16-0.64NA
Q4 2023
2/28/2024
4.85-0.16-0.64NA
Q3 2023
11/7/2023
1.34-0.35-1.40NA
Q2 2023
8/8/2023
1.23-0.47-1.88NA
Q1 2023
5/9/2023
8.00-0.52-2.08NA
Q4 2022
2/28/2023
6.06-0.44-1.76NA
Q3 2022
11/7/2022
6.64-0.61-2.44NA
Q2 2022
8/8/2022
5.25-0.55-2.20NA
Q1 2022
5/9/2022
3.18-0.59-2.36NA
Q4 2021
2/28/2022
4.39-0.68-2.72NA
Q3 2021
11/9/2021
9.52-0.63-2.52NA
Q2 2021
8/6/2021
12.37-0.59-2.36NA
Q1 2021
5/10/2021
14.92-0.50-2.00NA
Q4 2020
2/26/2021
18.18-0.42-1.68NA
Q3 2020
11/9/2020
22.92-0.33-1.32NA
Q2 2020
8/7/2020
20.27-0.33-1.32NA
Q1 2020
5/8/2020
9.81-0.35-1.40NA
Q4 2019
2/28/2020
8.66-0.34-1.36NA
Q3 2019
11/6/2019
1.98-0.35-1.40NA
Q2 2019
8/8/2019
3.16-0.36-1.44NA
Q1 2019
5/9/2019
5.910.702.802.1
Q4 2018
3/8/2019
4.52-0.97-3.88NA
Q3 2018
11/13/2018
6.04-0.75-3.00NA
Q2 2018
8/14/2018
12.91-0.54-2.16NA
Q1 2018
5/14/2018
16.51-0.54-2.16NA
Q4 2017
3/28/2018
15.92-0.61-2.44NA
Q3 2017
11/9/2017
17.10-0.35-1.40NA
Q2 2017
8/11/2017
15.42-6.33-25.32NA
MRSN PE History Chart
PeriodPriceGAAPTTMPE
Q3 2024
11/13/2024
2.63-0.09-0.61NA
Q2 2024
8/13/2024
1.35-0.20-0.87NA
Q1 2024
5/9/2024
2.46-0.16-1.14NA
Q4 2023
2/28/2024
4.85-0.16-1.50NA
Q3 2023
11/7/2023
1.34-0.35-1.78NA
Q2 2023
8/8/2023
1.23-0.47-2.04NA
Q1 2023
5/9/2023
8.00-0.52-2.12NA
Q4 2022
2/28/2023
6.06-0.44-2.19NA
Q3 2022
11/7/2022
6.64-0.61-2.43NA
Q2 2022
8/8/2022
5.25-0.55-2.45NA
Q1 2022
5/9/2022
3.18-0.59-2.49NA
Q4 2021
2/28/2022
4.39-0.68-2.40NA
Q3 2021
11/9/2021
9.52-0.63-2.14NA
Q2 2021
8/6/2021
12.37-0.59-1.84NA
Q1 2021
5/10/2021
14.92-0.50-1.58NA
Q4 2020
2/26/2021
18.18-0.42-1.43NA
Q3 2020
11/9/2020
22.92-0.33-1.35NA
Q2 2020
8/7/2020
20.27-0.33-1.37NA
Q1 2020
5/8/2020
9.81-0.35-1.40NA
Q4 2019
2/28/2020
8.66-0.34-0.35NA
Q3 2019
11/6/2019
1.98-0.35-0.98NA
Q2 2019
8/8/2019
3.16-0.36-1.38NA
Q1 2019
5/9/2019
5.910.70-1.56NA
Q4 2018
3/8/2019
4.52-0.97-2.80NA
Q3 2018
11/13/2018
6.04-0.75-2.44NA
Q2 2018
8/14/2018
12.91-0.54-2.04NA
Q1 2018
5/14/2018
16.51-0.54-7.83NA
Q4 2017
3/28/2018
15.92-0.61NANA
Q3 2017
11/9/2017
17.10-0.35NANA
Q2 2017
8/11/2017
15.42-6.33NANA
Quotes delayed 20 minutes

Email EnvelopeFree MRSN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Mersana Therapeutics (MRSN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

MRTX PE Ratio History
MRVI PE Ratio History
MSON PE Ratio History
MTCR PE Ratio History
MTEM PE Ratio History
MXCT PE Ratio History
MYGN PE Ratio History
MYMD PE Ratio History
NAOV PE Ratio History
NARI PE Ratio History
How should the MRSN historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Mersana Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this MRSN Historical PE Ratio page.

What is the average historical PE for MRSN based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The MRSN historical PE ratio using the annualized quarterly earnings method works out to 2.1.

What is the average historical PE for MRSN based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The MRSN historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the MRSN Historical PE Ratio information for Mersana Therapeutics' stock. The average MRSN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 2.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MRSN historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this MRSN historical PE result, against the recent PE: when this page was posted on 11/14/2024, the most recent closing price for MRSN had been 2.52, and the most recent quarterly earnings result, annualized, was 2.8. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent MRSN PE on 11/14/2024 based on annualized quarterly EPS was 0.9. Based on MRSN's history, that recent PE is low relative to the historical average, with the recent PE 57.1% lower than the historical average PE across our data set for Mersana Therapeutics.

For self directed investors doing their due diligence on MRSN or any other given stock, valuation analysis for MRSN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Mersana Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MRSN. Thanks for visiting, and the next time you need to research MRSN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: FRDM Videos, Institutional Holders of TBOW, Zomedica Earnings History.

 

MRSN Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.